These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 35396068)
1. Short- and Long-Term Response of Vagus Nerve Stimulation Therapy in Drug-Resistant Epilepsy: A Systematic Review and Meta-Analysis. Mao H; Chen Y; Ge Q; Ye L; Cheng H Neuromodulation; 2022 Apr; 25(3):327-342. PubMed ID: 35396068 [TBL] [Abstract][Full Text] [Related]
2. Vagus nerve stimulation for partial seizures. Panebianco M; Rigby A; Weston J; Marson AG Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD002896. PubMed ID: 25835947 [TBL] [Abstract][Full Text] [Related]
3. Vagus nerve stimulation for focal seizures. Panebianco M; Rigby A; Marson AG Cochrane Database Syst Rev; 2022 Jul; 7(7):CD002896. PubMed ID: 35833911 [TBL] [Abstract][Full Text] [Related]
4. Vagal Nerve Stimulation: Indications, Implantation, and Outcomes. Ohemeng KK; Parham K Otolaryngol Clin North Am; 2020 Feb; 53(1):127-143. PubMed ID: 31685239 [TBL] [Abstract][Full Text] [Related]
5. Vagus nerve stimulation for treatment of partial seizures: 2. Safety, side effects, and tolerability. First International Vagus Nerve Stimulation Study Group. Ramsay RE; Uthman BM; Augustinsson LE; Upton AR; Naritoku D; Willis J; Treig T; Barolat G; Wernicke JF Epilepsia; 1994; 35(3):627-36. PubMed ID: 8026409 [TBL] [Abstract][Full Text] [Related]
6. Neurostimulation in people with drug-resistant epilepsy: Systematic review and meta-analysis from the ILAE Surgical Therapies Commission. Touma L; Dansereau B; Chan AY; Jetté N; Kwon CS; Braun KPJ; Friedman D; Jehi L; Rolston JD; Vadera S; Wong-Kisiel LC; Englot DJ; Keezer MR Epilepsia; 2022 Jun; 63(6):1314-1329. PubMed ID: 35352349 [TBL] [Abstract][Full Text] [Related]
7. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States. Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763 [TBL] [Abstract][Full Text] [Related]
9. Vagus nerve stimulation: Surgical technique of implantation and revision and related morbidity. Giordano F; Zicca A; Barba C; Guerrini R; Genitori L Epilepsia; 2017 Apr; 58 Suppl 1():85-90. PubMed ID: 28386925 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of vagus nerve stimulation in 95 children of drug-resistant epilepsy with structural etiology. Xie H; Ma J; Ji T; Liu Q; Cai L; Wu Y Epilepsy Behav; 2023 Mar; 140():109107. PubMed ID: 36758359 [TBL] [Abstract][Full Text] [Related]
11. Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. George R; Salinsky M; Kuzniecky R; Rosenfeld W; Bergen D; Tarver WB; Wernicke JF Epilepsia; 1994; 35(3):637-43. PubMed ID: 8026410 [TBL] [Abstract][Full Text] [Related]
12. Norwegian population-based study of long-term effects, safety, and predictors of response of vagus nerve stimulation treatment in drug-resistant epilepsy: The NORPulse study. Kostov KH; Kostov H; Larsson PG; Henning O; Eckmann CAC; Lossius MI; Peltola J Epilepsia; 2022 Feb; 63(2):414-425. PubMed ID: 34935136 [TBL] [Abstract][Full Text] [Related]
13. The role of vagus nerve stimulation in genetic etiologies of drug-resistant epilepsy: a meta-analysis. Hajtovic S; LoPresti MA; Zhang L; Katlowitz KA; Kizek DJ; Lam S J Neurosurg Pediatr; 2022 Jun; 29(6):667-680. PubMed ID: 35303699 [TBL] [Abstract][Full Text] [Related]
14. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England. Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576 [TBL] [Abstract][Full Text] [Related]
15. Pre- and postoperative heart rate variability and vagus nerve stimulation in patients with drug-resistant epilepsy - A meta-analysis. Wu ML; Hu DM; Wang JJ; Liu XL; Liu L; Li Y; Jing W Epilepsy Behav; 2021 Oct; 123():108247. PubMed ID: 34418640 [TBL] [Abstract][Full Text] [Related]
16. Vagus nerve stimulation for treatment of drug-resistant epilepsy: a systematic review and meta-analysis. Lim MJR; Fong KY; Zheng Y; Chua CYK; Miny S; Lin JB; Nga VDW; Ong HT; Rathakrishnan R; Yeo TT Neurosurg Rev; 2022 Jun; 45(3):2361-2373. PubMed ID: 35217961 [TBL] [Abstract][Full Text] [Related]
17. Complications and safety of vagus nerve stimulation: 25 years of experience at a single center. Révész D; Rydenhag B; Ben-Menachem E J Neurosurg Pediatr; 2016 Jul; 18(1):97-104. PubMed ID: 27015521 [TBL] [Abstract][Full Text] [Related]
18. The Effectiveness of Vagus Nerve Stimulation in Drug-Resistant Epilepsy Correlates with Vagus Nerve Stimulation-Induced Electroencephalography Desynchronization. Sangare A; Marchi A; Pruvost-Robieux E; Soufflet C; Crepon B; Ramdani C; Chassoux F; Turak B; Landre E; Gavaret M Brain Connect; 2020 Dec; 10(10):566-577. PubMed ID: 33073582 [No Abstract] [Full Text] [Related]
19. Outcome of vagus nerve stimulation for drug-resistant epilepsy: the first three years of a prospective Japanese registry. Kawai K; Tanaka T; Baba H; Bunker M; Ikeda A; Inoue Y; Kameyama S; Kaneko S; Kato A; Nozawa T; Maruoka E; Osawa M; Otsuki T; Tsuji S; Watanabe E; Yamamoto T Epileptic Disord; 2017 Sep; 19(3):327-338. PubMed ID: 28832004 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety following two or more years of vagus nerve stimulation (VNS Therapy) in pediatric patients with drug-resistant epilepsy enrolled in a Russian VNS Registry. Feygina AA; Koshelyaevskaya YN; Dibué M; Voronkova KV; Klochkov MN; Koroleva NY; Ivanov SS; Bolshakova ES; Fatykhova EF Brain Behav; 2023 Jul; 13(7):e3076. PubMed ID: 37254623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]